NOP2 and hepatocellular carcinoma: Knockdown of NOP2 increased the inhibition rate and decreased the 50% inhibitory concentration values of sorafenib in HCC-LM3R and Huh-7R cells, whereas in cells overexpressing NOP2, the inhibition rate was lower and 50% inhibitory concentrationvalues were higher (Fig. S3A and B).